170 related articles for article (PubMed ID: 38067210)
1. Hemoglobin Subunit Theta 1 Promotes Proliferation by Reducing Reactive Oxygen Species in Lung Adenocarcinoma.
Kim K; Choi EY; Ahn HM; Kim DG; Kim YJ
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067210
[TBL] [Abstract][Full Text] [Related]
2. DHX9 inhibits epithelial-mesenchymal transition in human lung adenocarcinoma cells by regulating STAT3.
Yan X; Chang J; Sun R; Meng X; Wang W; Zeng L; Liu B; Li W; Yan X; Huang C; Zhao Y; Li Z; Yang S
Am J Transl Res; 2019; 11(8):4881-4894. PubMed ID: 31497206
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Long Non-Coding RNA ZXF2 Promotes Lung Adenocarcinoma Progression Through c-Myc Pathway.
Yang ZT; Li Z; Wang XG; Tan T; Yi F; Zhu H; Zhao JP; Zhou XF
Cell Physiol Biochem; 2015; 35(6):2360-70. PubMed ID: 25896422
[TBL] [Abstract][Full Text] [Related]
5. CASTOR1 suppresses the progression of lung adenocarcinoma and predicts poor prognosis.
Zhou X; Cheng Z; Chen H; Shi S; Wang X; Orang M; Zhao J
J Cell Biochem; 2018 Dec; 119(12):10186-10194. PubMed ID: 30132978
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of HSDL2 inhibits lung adenocarcinoma progression via down-regulating AKT2 expression.
Shi Y; Mao Z; Huang Y; Sun Y; Cao Q; Yin X; Huang J; Zhang Q
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32211805
[TBL] [Abstract][Full Text] [Related]
7. RFC3 induces epithelial‑mesenchymal transition in lung adenocarcinoma cells through the Wnt/β‑catenin pathway and possesses prognostic value in lung adenocarcinoma.
Gong S; Qu X; Yang S; Zhou S; Li P; Zhang Q
Int J Mol Med; 2019 Dec; 44(6):2276-2288. PubMed ID: 31661124
[TBL] [Abstract][Full Text] [Related]
8. High Expression of Krüppel-like Factor 7 Indicates Unfavorable Clinical Outcomes in Patients with Lung Adenocarcinoma.
Niu R; Tang Y; Xi Y; Jiang D
J Surg Res; 2020 Jun; 250():216-223. PubMed ID: 32092599
[TBL] [Abstract][Full Text] [Related]
9. Linc00152 promotes Cancer Cell Proliferation and Invasion and Predicts Poor Prognosis in Lung adenocarcinoma.
Zhang PP; Wang YQ; Weng WW; Nie W; Wu Y; Deng Y; Wei P; Xu MD; Wang CF
J Cancer; 2017; 8(11):2042-2050. PubMed ID: 28819405
[No Abstract] [Full Text] [Related]
10. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
[TBL] [Abstract][Full Text] [Related]
11. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
PeerJ; 2023; 11():e16166. PubMed ID: 37790630
[TBL] [Abstract][Full Text] [Related]
12. Long Non-Coding RNA AP000695.2 Acts as a Novel Prognostic Biomarker and Regulates the Cell Growth and Migration of Lung Adenocarcinoma.
Wang C; Guo J; Jiang R; Wang C; Pan C; Nie Z; Jiang X
Front Mol Biosci; 2022; 9():895927. PubMed ID: 35685240
[TBL] [Abstract][Full Text] [Related]
13. PPP1R14D promotes the proliferation, migration and invasion of lung adenocarcinoma via the PKCα/BRAF/MEK/ERK signaling pathway.
Cao H; Wang Z; Wang Y; Ye L; Li R; Xue Y; Li K; Di T; Li T; Fan Z; Liu Y; Guo J; Yao H; Ge C
Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36263632
[TBL] [Abstract][Full Text] [Related]
14. ATF1 promotes the malignancy of lung adenocarcinoma cells by transcriptionally regulating ZNF143 expression.
Mei J; Liu Y; Sheng Y; Liu Y; Chen L; Wang H; Cheng M; Zhai Z; Xu L
Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):769-782. PubMed ID: 37158648
[TBL] [Abstract][Full Text] [Related]
15. Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma.
Zhao CC; Chen J; Niu RF; Liu Y; Zhang CG
Oncol Rep; 2018 Dec; 40(6):3392-3404. PubMed ID: 30272365
[TBL] [Abstract][Full Text] [Related]
16. Thymosin β10 promotes tumor-associated macrophages M2 conversion and proliferation via the PI3K/Akt pathway in lung adenocarcinoma.
Zeng J; Yang X; Yang L; Li W; Zheng Y
Respir Res; 2020 Dec; 21(1):328. PubMed ID: 33349268
[TBL] [Abstract][Full Text] [Related]
17. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma.
Wang Y; Mei X; Song W; Wang C; Qiu X
BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts-derived gamma-glutamyltransferase 5 promotes tumor growth and drug resistance in lung adenocarcinoma.
Wei JR; Dong J; Li L
Aging (Albany NY); 2020 Jul; 12(13):13220-13233. PubMed ID: 32640421
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung Adenocarcinoma.
Chen H; Xia R; Jiang L; Zhou Y; Xu H; Peng W; Yao C; Zhou G; Zhang Y; Xia H; Wang Y
Front Oncol; 2021; 11():619013. PubMed ID: 33767988
[TBL] [Abstract][Full Text] [Related]
20. Keratin 17 Promotes Lung Adenocarcinoma Progression by Enhancing Cell Proliferation and Invasion.
Liu J; Liu L; Cao L; Wen Q
Med Sci Monit; 2018 Jul; 24():4782-4790. PubMed ID: 29991674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
